Publication | Open Access

Trabectedin and olaparib in patients with advanced and non-resectable bone and soft-tissue sarcomas (TOMAS): an open-label, phase 1b study from the Italian Sarcoma Group

Non-resectable BoneSurgical OncologyMedicineSoft-tissue SarcomasPathologySurgeryItalian Sarcoma GroupOncologyOrthopaedic Surgery